Biomedical subjects
Mark E Neumann
Publications and source records attributed to Mark E Neumann.
Thriving nephrology practice embraces technology, CKD care, research.
Explore the source record for details and available documents.
KDIGO takes clinical practice guidelines to a global level.
Explore the source record for details and available documents.
Re-engineering the ESRD Program amid Medicare reform.
Explore the source record for details and available documents.
Renal technology advancing--but who will pay?
Explore the source record for details and available documents.
Chronically motivated. Hartwell works 24/7 to improve the patient-caregiver relationship.
Explore the source record for details and available documents.
Drugs take the spotlight in steering clinical, economic direction for ESRD.
Explore the source record for details and available documents.
"Fistula first" initiative pushes for new standards in access care.
Explore the source record for details and available documents.
NN&I workload and compensation survey/Part 3--Patient assessment, documentation, and communication issues.
Explore the source record for details and available documents.
Linking reimbursement and quality.
Explore the source record for details and available documents.
FMCNA says data shows higher risk of mortality among patients on reuse. Industry questions bias in reporting.
Explore the source record for details and available documents.
Renal care providers: stages of growth.
Explore the source record for details and available documents.
Medicare prescription plan, threat to AWP could impact the ESRD drug market.
Explore the source record for details and available documents.
"Giving back" on their own time for nearly four decades.
Explore the source record for details and available documents.
Renal care organizations back new CKD initiative.
Explore the source record for details and available documents.
More frequent hemodialysis: an overview.
Explore the source record for details and available documents.
The cost of medical liability. Part 1.
Explore the source record for details and available documents.
Consumers concerned about malpractice costs but wary of limiting jury awards. Part 2.
Explore the source record for details and available documents.